Tweet
ARMENIAN PHARMACEUTISTS SHOULD ENSURE GOOD PRACTICE OF NOT ONLY MANUFACTURING BUT ALSO SALE OF MEDICAMENTS
ArmInfo
2009-12-01 17:03:00
ArmInfo. Armenian pharmaceutists should ensure good practice of not
only manufacturing but also sale of medicaments, Australian expert
Michael Kimber told ArmInfo correspondent. When a producer applies
for registration, it should present the medicament keeping conditions.
These conditions, including the temperature, should be observed in the
whole chain from the producer to the consumer. According to the current
international standards, a producer should know how these conditions
are observed and provide advisory support if necessary, he said.
The local producers and importers observe this practice not always,
however, this problem concerns not only Armenia, he added. The
problem of not only adherence to the standards, but also the problem
of adulterants is still relevant today. All over the world this
business is estimated at approximately 75 bln USD per year, and in
Armenia this problem is also urgent, and its settlement needs joint
efforts of professional pharmaceutists and state bodies, Kimber said.
To recall, Kimber visited Armenia in May 2009 to hold GMP training
courses for specialists. Then courses were held for trainers. The
Armenian specialists, which passed these courses, received a right to
hold GMP standard training courses in Armenia. At present GXP Center of
Excellence is holding training courses of good manufacturing practice
and good distribution practice for pharmaceutical products.
From: Emil Lazarian | Ararat NewsPress
ArmInfo
2009-12-01 17:03:00
ArmInfo. Armenian pharmaceutists should ensure good practice of not
only manufacturing but also sale of medicaments, Australian expert
Michael Kimber told ArmInfo correspondent. When a producer applies
for registration, it should present the medicament keeping conditions.
These conditions, including the temperature, should be observed in the
whole chain from the producer to the consumer. According to the current
international standards, a producer should know how these conditions
are observed and provide advisory support if necessary, he said.
The local producers and importers observe this practice not always,
however, this problem concerns not only Armenia, he added. The
problem of not only adherence to the standards, but also the problem
of adulterants is still relevant today. All over the world this
business is estimated at approximately 75 bln USD per year, and in
Armenia this problem is also urgent, and its settlement needs joint
efforts of professional pharmaceutists and state bodies, Kimber said.
To recall, Kimber visited Armenia in May 2009 to hold GMP training
courses for specialists. Then courses were held for trainers. The
Armenian specialists, which passed these courses, received a right to
hold GMP standard training courses in Armenia. At present GXP Center of
Excellence is holding training courses of good manufacturing practice
and good distribution practice for pharmaceutical products.
From: Emil Lazarian | Ararat NewsPress